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Abstract: The β-galactosidase from Bacillus circulans was covalently attached to aldehyde-activated
(glyoxal) agarose beads and assayed for the continuous production of galactooligosaccharides
(GOS) in a packed-bed reactor (PBR). The immobilization was fast (1 h) and the activity of the
resulting biocatalyst was 97.4 U/g measured with o-nitrophenyl-β-D-galactopyranoside (ONPG).
The biocatalyst showed excellent operational stability in 14 successive 20 min reaction cycles at 45 ◦C
in a batch reactor. A continuous process for GOS synthesis was operated for 213 h at 0.2 mL/min and
45 ◦C using 100 g/L of lactose as a feed solution. The efficiency of the PBR slightly decreased with
time; however, the maximum GOS concentration (24.2 g/L) was obtained after 48 h of operation,
which corresponded to 48.6% lactose conversion and thus to maximum transgalactosylation
activity. HPAEC-PAD analysis showed that the two major GOS were the trisaccharide
Gal-β(1→4)-Gal-β(1→4)-Glc and the tetrasaccharide Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc.
The PBR was also assessed in the production of GOS from milk as a feed solution. The stability of the
bioreactor was satisfactory during the first 8 h of operation; after that, a decrease in the flow rate was
observed, probably due to partial clogging of the column. This work represents a step forward in the
continuous production of GOS employing fixed-bed reactors with immobilized β-galactosidases.
Keywords: galacto-oligosaccharides; prebiotics; transglycosylation; betα-galactosidase; covalent
immobilization; Bacillus circulans; glyoxal agarose; fixed-bed reactor
1. Introduction
In addition to the hydrolysis of lactose, β-galactosidases (β-D-galactoside galactohydrolases,
EC 3.2.1.23) catalyze transgalactosylation reactions in which lactose—or the released glucose
and galactose—act as galactosyl acceptors, yielding a series of condensation products called
galactooligosaccharides (GOS) [1,2]. The ratio between lactose hydrolysis and GOS synthesis depends
crucially on the concentration of lactose, the temperature of the reactor and the intrinsic enzyme
properties [1,3,4].
GOS constitute a group of prebiotics that modulate the colonic microbiota, providing health
benefits such as an improvement in mineral absorption and the prevention of colon cancer [5,6].
The major applications of GOS are in beverages and mostly in infant milk formulas due to the similar
benefits of GOS and human milk oligosaccharides [7].
The commercial applications of GOS in the food industry could be increased if the cost of the
production process was reduced. Immobilization of enzymes offers advantages for the industrial
development of biocatalytic processes, such as easy separation and reuse of the biocatalyst—making
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product recovery easier—and enhancement of enzyme resistance against inactivation by different
denaturants [8,9]. Covalent immobilization has the advantage of forming robust linkages between
the enzyme and the carrier, which minimizes the loss of activity caused by enzyme leakage from the
support [10], extends its lifetime by protecting the three-dimensional structure of the protein [11] and
allows the development of continuous processes.
The use of immobilized β-galactosidases in continuous bioreactors has mostly been applied to
the hydrolysis of lactose in cheese whey [12–14]. In contrast, the production of GOS in continuous
bioreactors has been scarcely studied [15–17].
The β-galactosidase from Bacillus circulans synthesizes GOS with a major presence of β(1→4)
bonds [18]. Compared with other β-galactosidases, this enzyme gives rise to a notable GOS yield
(approximately 49% w/w, starting from 400 g/L lactose) [19]. In addition, it is appropriate for the dairy
industry since it presents notable activity at pH 6.7 and is not inhibited by calcium [20]. Using milk as
a substrate, the enzyme also displays a certain degree of transgalactosylation activity with a maximum
GOS yield of 15% at approximately 50% lactose conversion [21]. The B. circulans β-galactosidase
has been immobilized by different strategies which include adsorption on Duolite followed by
glutaraldehyde cross-linking [22], covalent attachment to epoxy-activated acrylic supports [23] or
alginate entrapment [17].
In this work we have evaluated the continuous production of GOS using a reactor packed
with B. circulans β-galactosidase covalently attached to aldehyde-activated (glyoxal) agarose beads.
This support was previously tested in batch but not in continuous packed-bed reactors (PBR),
by Urrutia et al. [24]. The operational stability of the immobilized biocatalysts for the production of
GOS was assessed.
2. Results and Discussion
2.1. Immobilization of β-Galactosidase from B. circulans on Glyoxal Agarose Resin
The immobilization of β-galactosidase from B. circulans was carried out by covalent attachment
to glyoxal agarose beads, whose diameter in a dried state is around 50 µm (Figure 1). The binding
chemistry between the amino groups of the protein and the glyoxyl moieties of the support is rather
simple and gives rise to robust linkages between the enzyme and the carrier [25–27]. However,
the immobilization must be performed at alkaline pH in order to deprotonate amino groups and
thus enhance their nucleophilicity [28]. For that reason, the stability of B. circulans β-galactosidase at
pH 10.0 was assessed in order to determine the optimal immobilization conditions for this enzyme.
As shown in Figure 2A, B. circulans β-galactosidase maintained nearly 40% of its initial activity after
174 h incubation in 0.1 M sodium bicarbonate buffer (pH 10.0). Given that covalent binding of proteins
to aldehyde-activated carriers typically takes place in a few hours, we concluded that pH 10.0 was
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Figure 1. Scanning electron microscopy (SEM) pictures of glyoxal agarose beads: (Left) 400×;
(Right) 1000×.
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Figure 2. (A) Stability of soluble β-galactosidase from B. circulans in the coupling buffer (0.1 M sodium
bicarbonate pH 10.0); (B) Progress of covalent immobilization of β-galactosidase from B. circulans on
glyoxal agarose, monitored by measuring the residual activity in the supernatant.
The cov lent coupl ng of B. circulans β-galactosidase to glyoxal agarose, followed by the
disappearance of activity in the supernatant, was extremely fast. As illus ted n Figure 2B,
the incubation time required for quantitative coupling was less than 1 h. This fact contrasts with
epoxy-activated carriers, such as Eupergit C or Sepabeads EP, which require long incubation times
(24–48 h) [23]. We observed a satisfactory recovery of activity in the immobilized biocatalyst.
The so-called apparent (experimental) activity of the immobilized biocatalyst [29,30], measured with
o-nitrophenyl-β-D-galactopyranoside (ONPG), was 97.4 U/g. It is worth mentioning that the treatment
with sodium borohydride to reduce the semi-stable Schiff bases initially formed in the immobilization
process caused negligible loss of activity.
2.2. Operational Stability in Batch Reactor
The stability of B. circulans β-galactosidase immobilized onto glyoxal agarose beads was studied
at 45 ◦C in a batch reactor measuring the activity of the biocatalyst with ONPG in a sequence
of reaction cycles, following methodolog recently developed in our laboratory [31]. Figure 3
illustrates the perational stability of the biocatalyst in 14 successive r action cycles of 20 min each.
As shown, the biocatalyst maintained nearly 100% of its initial activity after 14 cycles (280 min) and
the corresponding washings. These results were in accordance with those described by Urrutia et al.
(2013), who analyzed the stability of this enzyme in a batch reactor after immobilization on several
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Figure 3. Reuse assay in a batch reactor of β-galactosidase from B. circulans immobilized onto glyoxal
agarose beads. After each reaction cycle (20 min), the biocatalyst was filtered and washed with buffer.
Reaction conditions: 15 mM ONPG in 0.1 M sodium acetate buffer (pH 5.5), 45 ◦C.
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2.3. Effect of Lactose Conversion on GOS Yield with Immobilized B. circulans β-Galactosidase
Before setting up a continuous reactor, we analyzed the effect of lactose conversion on the
production of GOS with the immobilized biocatalyst. The maximum GOS yield depends on the relative
rates of transgalactosylation and hydrolysis [18]. As the reaction progresses, the lactose concentration
decreases and the GOS concentration increases until it reaches a maximum. At this point, the rate of
GOS synthesis is the same as its rate of hydrolysis. Thereafter, GOS hydrolysis becomes the major
process and the amount of GOS decreases until a thermodynamic equilibrium is reached.
Figure 4 illustrates the GOS production profile with the β-galactosidase from B. circulans
immobilized on glyoxal agarose beads, using 100 g/L lactose. This lactose concentration was selected,
considering further development of a continuous reactor, to assure good fluidity, thus minimizing
clogging of the fixed bed. The GOS profile showed the typical pattern with a maximum GOS
yield at approximately 50% of lactose conversion, followed by a progressive decrease of the GOS
concentration [20]. The maximum GOS concentration was obtained at a similar lactose conversion as
the soluble B. circulans β-galactosidase [18,19,21]. At this point, the GOS yield was approximately 25%
(w/w) (Figure 4), referring to the total amount of sugars in the mixture. This value was intermediate
between the value reported for a starting 400 g/L lactose solution (49% GOS yield) [19] and the value
obtained with skim milk (45 g/L lactose, 15%–17% GOS yield) [19,21], demonstrating the notable effect
of the substrate concentration on the transglycosylation activity [32].
As shown in Figure 4, trisaccharides were the major GOS synthesized, as occurred with the soluble
enzyme [19]. Once the maximum GOS concentration was achieved, the decrease in trisaccharide and
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Fig re 4. ffect of lactose co versio o S (galactooligosacc ari es) yiel a ro ct istrib tio
. circ la s -galactosidase immobilized on glyoxal agarose beads. Conditions: 100 g/L lactose,
0.1 M acetate buffer (pH 5.5), 45 ◦C.
2.4. GOS Synthesis in PBR with Immobilized B. circulans β-Galactosidase
GOS production in continuous mode by β-galactosidase from B. circulans has been scarcely
explored; most of the studies were carried out in continuous stirred tank reactors (CSTRs) [22,23].
To our knowledge, for the development of packed-bed reactors (PBR) this enzyme has been
immobilized in Eupergit C [16] and calcium alginate [17]. In our work, a tubular packed-bed
reactor (PBR) of 1 mL was filled with 680 mg (66 U) of the immobilized biocatalyst. A continuous
process for GOS synthesis was operated at 0.2 mL/min and 45 ◦C using 100 g/L of lactose as a feed
solution. This temperature was a compromise between enzyme stability and fluidity of the lactose
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solution. In addition, it is well reported that the transglycosylation-to-hydrolysis ratio increases with
temperature [33,34]. The bioreactor was operated continuously for nine days and samples were taken
at different times and analyzed by HPAEC-PAD to determine the GOS yield and product composition.
Figure 5 illustrates the evolution of the GOS yield and lactose conversion during the 213 h
of continuous operation. At the starting point, the remaining lactose concentration was 13.5 g/L.
This high lactose conversion (86.5%) gave rise to a GOS yield (16.5%) which is far from the highest
value (Figure 4). As the process progressed, the activity of the immobilized biocatalyst decreased,
probably due to enzyme inactivation or diffusional restrictions. As a result, the maximum GOS
concentration (24.2 g/L) was obtained after 48 h of operation, at the point at which lactose conversion
reached 48.6%, in accordance with our previous findings (Figure 4). Thereafter, the composition of
the outlet was progressively enriched in lactose, thus decreasing the amount of GOS. After the first
144 h, the concentration of the outlet was maintained nearly constant, with an average total GOS
concentration of 10 g/L and 82 g/L lactose. This biphasic behavior (an initial activity decay followed by
the maintenance of a certain degree of activity) could be related to the presence of various populations
of immobilized β-galactosidases showing a different number of covalent bonds with the support and
thus exhibiting diverse operational stability under reactor conditions [35–37].
Considering the volume of the bioreactor and the concentration of the total GOS, the space-time
yield varied between 2900 and 6900 g GOS/day·L throughout the operation time of the reactor.
Using immobilized β-galactosidases from different sources (Aspergillus oryzae, Aspergillus candidus,
Bullera singularis), the productivity of the PBR was reported between 105 and 2540 g GOS/day·L [38–40].
With β-galactosidase from B. circulans immobilized in Eupergit C 250L, Warmerdam et al. also




reported  that  the  transglycosylation‐to‐hydrolysis  ratio  increases  with  temperature  [33,34].  The 
bioreactor was operated continuously for nine days and samples were taken at different times and 








progressively  enriched  in  lactose,  thus decreasing  the  amount  of GOS. After  the  first  144 h,  the 
concentration of the outlet was maintained nearly constant, with an average total GOS concentration 







singularis),  the productivity of  the PBR was reported between 105 and 2540 g GOS/day∙L  [38–40]. 
With  β‐galactosidase  from  B.  circulans  immobilized  in  Eupergit C  250L, Warmerdam  et  al.  also 








galactosidase  from B.  circulans. Figure 6  shows  the HPAEC‐PAD  chromatograms of  the outlet at 
different operation times. Peaks 1, 2 and 4 correspond to galactose, glucose and lactose, respectively. 
The galactose peak is lower than that of glucose due to the transgalactosylation reaction to produce 
GOS. As  illustrated  in  the chromatograms,  the  two main GOS synthesized by  the β‐galactosidase 
from  B.  circulans were  identified  as  the  trisaccharide  Gal‐β(1→4)‐Gal‐β(1→4)‐Glc  (4′‐galactosyl‐
lactose, peak  9)  and  the  tetrasaccharide Gal‐β(1→4)‐Gal‐β(1→4)‐Gal‐β(1→4)‐Glc  (peak  10). These 
results  are  in  accordance with  those  obtained with  the  soluble  enzyme  [19,21]  and  confirm  the 
preference  of  this  β‐galactosidase  to  form  β(1→4)  linkages. Most  of  the minor  peaks were  also 
Figure 5. Progress of GOS and lactose concentration during the opera ion of the PBR
(packed-bed reactor) packed with β-galactosidase from B. circulans immobilized on glyoxal agarose
beads. Reactor conditions: feed solution, 100 g/L lactose; flow rate, 0.2 mL/min; pH 5.5, 45 ◦C.
2.5. Specificity of GOS Production in PBR
We analyzed the GOS composition at the outlet during operation of the PBR packed with
β-galactosidase from B. circulans. Figure 6 shows the HPAEC-PAD chromatograms of the outlet
at different operation times. Peaks 1, 2 and 4 correspond to galactose, glucose and lactose, respectively.
The galactose peak is lower than that of glucose due to the transgalactosylation reaction to produce
GOS. As illustrated in the chromatograms, the two main GOS synthesized by the β-galactosidase from
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B. circulans were identified as the trisaccharide Gal-β(1→4)-Gal-β(1→4)-Glc (4′-galactosyl-lactose,
peak 9) and the tetrasaccharide Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc (peak 10). These results are
in accordance with those obtained with the soluble enzyme [19,21] and confirm the preference of this
β-galactosidase to form β(1→4) linkages. Most of the minor peaks were also identified, namely
Gal-β(1→6)-Glc (allolactose), Gal-β(1→3)-Glc, Gal-β(1→3)-Gal (3-galactobiose), Gal-β(1→4)-Gal
(4-galactobiose) and Gal-β(1→6)-Gal-β(1→4)-Glc (6′-galactosyl-lactose).
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with  the  concomitant  reduction of  the GOS yield  (from 18.0%  to 14.4%).  In  contrast with  results 
obtained  employing  lactose  solutions,  we  observed  that  after  8  h,  the  flow  rate  progressively 
diminished,  probably  due  to  partial  clogging  of  the  column, which  could  be  caused  by  certain 
components of skim milk and/or microbial contamination. 
HPAEC‐PAD analyses (Figure 7, bottom) confirmed that the two main GOS synthesized using 
milk as  the  feed solution were  the  trisaccharide Gal‐β(1→4)‐Gal‐β(1→4)‐Glc (4′‐galactosyl‐lactose) 
Figure 6. HP EC-PAD analysis of the PBR outlet at various operation times (0, 48 and
213 h). Peaks: (1) Galactose; (2) Glucose; (3) Allolactose; (4) Lactose; (5) 3-Galact biose;
(6) 4-G lactobiose; (7) 6′-Galactosyl-lactose; (8) Gal-β(1→3)-Glc; (9) 4′-Galactosyl-lactose;
(10) Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc.
Table 1 su marizes t concentration of the wo major GOS and the rest of the products at different
operation times. At the point of the maximum GOS concentration (48 h), the yield was approximately
24%, mostly due to the presence of 4′-galactosyl-lactose (15.7%) followed by the tetrasaccharide
Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc (5.3%). The contribution of other oligosaccharides to the
total amount of GOS was less significant (3.3%). At the end of operation, the outlet contained mainly
lactose (83%), glucose (6.7%) and 4′-galactosyl-lactose (9%) as the only appreciable GOS (Figure 6).
Table 1. Composition of the reaction mixtures at the beginning of operation (0 h), maximum GOS

















0 26.1 43.9 13.6 3.1 0.7 12.6 16.5
48 4.1 23.0 48.6 15.7 5.3 3.3 24.3
213 0.3 6.7 83.0 9.0 0.7 0.3 10.0
1 Reactor conditions: feed solution, 100 g/L lactose; flow rate, 0.2 mL/min; pH 5.5, 45 ◦C;
2 Gal-β(1→4)-Gal-β(1→4)-Glc; 3 Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc.
2.6. Continuous GOS Production using Milk as Feed Solution
We analyzed whether the fixed-bed reactor could be employed for the continuous production of
GOS using milk as the feed solution. Previously we found that the soluble B. circulans β-galactosidase
was able to synthesize GOS in milk [21], with a maximum GOS concentration of approximately 8.1 g/L
at 4 ◦C. This yield corresponded to 17.6% (w/w) of the total carbohydrates in milk and was achieved
when around 50% of the initial lactose had disappeared [41]. For that reason, we adjusted the flow
rate in the PBR to obtain a lactose conversion close to 50% at zero time. Figure 7 (top) sh ws that the
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conversion of lactose lowered from 44% to 34% during the first 8 h of operation, with the concomitant
reduction of the GOS yield (from 18.0% to 14.4%). In contrast with results obtained employing
lactose solutions, we observed that after 8 h, the flow rate progressively diminished, probably due to
partial clogging of the column, which could be caused by certain components of skim milk and/or
microbial contamination.
HPAEC-PAD analyses (Figure 7, bottom) confirmed that the two main GOS synthesized using
milk as the feed solution were the trisaccharide Gal-β(1→4)-Gal-β(1→4)-Glc (4′-galactosyl-lactose)
and the tetrasaccharide Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc. The enzyme specificity was thus
not altered by milk components.
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Figure 7. Top: Operationa stability at 4 ◦C during the first 8 h of the PBR co ining
the β-galactosidase from B. circulans immobilized in glyoxal agarose, using ski milk as feed
solution. Bottom: HPAEC-PAD analysis of the PBR outlet at 2.5 h The peaks correspond
to: (1) Galactose; (2) Glucose; (4) Lactose; (8) Gal-β(1→3)-Glc; (9) 4′-Galactosyl-lactose;
(10) Gal-β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc.
3. Materials and Methods
3.1. Materials
Biolactase NTL-CONC, a commercial β-galactosidase preparation from Bacillus circulans,
was supplied by Biocon (Barcelona, Spain). Glucose, galactose, lactose and
o-nitrophenyl-β-D-galactopyranoside (ONPG) were from Sigma-Aldrich (Tres Cantos, Madrid, Spain).
6-Galactobiose, 4-gal ctobiose, 6-O-β-galactosyl-glucose ( llolactose) and 4′-O-β-galact syl-lactos
were from Carbosynth (Berkshire, UK). High Density Glyoxal Agarose Resin 4BCL-GH1 (spherical,
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50–150 µm diameter, 40–60 µmol glyoxyl·mL−1 gel, coupling capacity 15–20 mg BSA·mL−1 gel)
was purchased from Agarose Bead Technologies (Torrejon de Ardoz, Madrid, Spain). Skim milk
“Hacendado” was purchased from a local Mercadona Supermarket (Madrid, Spain). All other reagents
and solvents were of the highest available purity and used as purchased.
3.2. Activity Assay
The enzymatic activity towards o-nitrophenyl-β-D-galactopyranoside (ONPG) was measured
monitoring the release of o-nitrophenol at 405 nm using a microplate reader (Versamax, Molecular
Devices, Sunnyvale, CA, USA). The reaction was started by adding 10 µL of the soluble enzyme
(conveniently diluted) to 190 µL of 15 mM ONPG in 0.1 M sodium acetate buffer (pH 5.5). The increase
of absorbance at 405 nm was followed in continuous mode during 5 min. The extinction molar
coefficient of o-nitrophenol at pH 5.5 was determined (537 M−1·cm−1). One unit (U) of activity
was defined as that corresponding to the hydrolysis of 1 µmol of ONPG per min. The activity of
the immobilized biocatalyst was determined in an Eppendorf tube mixing approximately 5 mg of
biocatalyst with 1 mL of 15 mM ONPG in 0.1 M sodium acetate buffer (pH 5.5). The mixture was
maintained at 25 ◦C and 900 rpm for 20 min in a Thermo Shaker TS-100 (Boeco, Hamburg, Germany).
The increase of absorbance at 405 nm was measured in endpoint mode.
3.3. Covalent Immobilization
The support (3.3 g) was washed twice with distilled water to eliminate the preservatives.
The immobilization was carried out by mixing the support with 1 mL of Biolactase and 9 mL of
0.1 M sodium bicarbonate buffer pH 10.0. The mixture was gently stirred at 25 ◦C in a rotary
incubator (Enviro-Genie SI-1202, Scientific Industries, Inc., Bohemia, NY, USA) at 35 rpm until the
remaining activity in the supernatant was negligible. After that, 10.2 mg of NaBH4 was added to
the suspension and the mixture incubated for 30 min at room temperature and 900 rpm in an orbital
shaker (Vortemp 1550, Labnet International, Edison, NJ, USA). The resulting biocatalyst was washed
twice with 25 mM sodium phosphate buffer (pH 7.0), and then washed thoroughly several times with
distilled water.
3.4. Operational Stability in Batch Reactor
A protocol previously developed in our laboratory was followed [31]. For each cycle,
the immobilized biocatalyst (approx. 58 mg) was incubated in a rotary incubator (Enviro-Genie
SI-1202, Scientific Industries, Inc.) at 35 rpm and 45 ◦C with 600 µL of 15 mM ONPG solution in
micro-centrifuge filter tube. After 20 min, the immobilized enzyme was separated from the reaction
solution by centrifugation at 5000× g. The supernatant was mixed with 800 µL of 0.4 M Na2CO3
in order to inactivate any possible leaked enzyme and the absorbance at 405 nm was measured.
The immobilized biocatalyst was washed twice with 0.1 M sodium acetate buffer (pH 5.5). The relative
enzymatic activity of each cycle was referred to the apparent activity of the first cycle.
3.5. GOS Production in Continuous Packed-Bed Reactor
The immobilized biocatalyst containing the β-galactosidase from B. circulans was packed in a
1-mL EB-Ctg1-1 cartridge (6.2 mm inner column diameter, Agarose Bead Technologies). The inlet of
the column was connected to a peristaltic pump P-1 (GE Healthcare, Madrid, Spain)), as shown in
Figure 8, in order to precisely control the flow of the feeding solution (100 g/L lactose in 0.1 M sodium
acetate buffer pH 5.5 or skim milk).
Catalysts 2016, 6, 189 9 of 12
Catalysts 2016, 6, 189  8 of 11 
 












mM sodium phosphate buffer  (pH 7.0), and  then washed  thoroughly several  times with distilled 
water. 
3.4. Operational Stability in Batch Reactor 
A  protocol  previously  developed  in  our  laboratory was  followed  [31].  For  each  cycle,  the 
immobilized biocatalyst (approx. 58 mg) was incubated in a rotary incubator (Enviro‐Genie SI‐1202, 













Figure 8. Schematic diagram of the continuous PBR used in this study to synthesize GOS. Figure 8. Schematic diagram of the continuous PBR used in this study to synthesize GOS.





where Vr is the volume of the PBR in mL, ε is the porosity of the bed and ∅ the flow rate in
mL/min, and assuming a porosity factor of 0.60—as reported for other similar swellable hydrophilic
resins [16] the residence time at 0.2 mL/min (typically used in this work) would be close to 2 min.
Both the bioreactor and the feeding solution were maintained at 45 ◦C in a thermostated chamber
(Ovan, Barcelona, Spain). At different times, 200 µL aliquots were taken at the outlet stream of the
bioreactor and mixed with 800 µL of 0.4 M Na2CO3 to inactivate any leaked enzyme. Samples were
filtered using 0.45 µm nylon filters coupled to 1 mL sterile syringes, and diluted 1:400 with water
before HPAEC-PAD analysis.
3.6. High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD)
Carbohydrate analysis was performed by HPAEC-PAD on a ICS3000 Dionex system (Dionex Corp.,
Sunnyvale, CA, USA) consisting of a SP gradient pump, an AS-HV autosampler and an electrochemical
detector with a gold working electrode and Ag/AgCl as reference electrode. All eluents were
degassed by flushing with helium. A pellicular anion-exchange 4 × 250 mm Carbo-Pack PA-1 column
(Dionex Sunnyvale, CA, USA) connected to a CarboPac PA-1 guard column was used at 30 ◦C.
For eluent preparation, MilliQ water and 50% (w/v) NaOH (Sigma-Aldrich) were used. The initial
mobile phase was 15 mM NaOH at 1.0 mL/min for 12 min. A gradient from 15 mM to 200 mM NaOH
was carried out at the same flow rate in 15 min, and the latter was maintained for 50 min. The peaks
were analyzed using Chromeleon software (Dionex Sunnyvale, CA, USA, 2008)). Identification of
the different carbohydrates was done based on commercial standards and previously purified and
characterized GOS [19,42,43].
3.7. Scanning Electron Microscopy
Scanning electron microscopy (SEM) was performed using a S-3000N microscope
(Hitachi, Schaumburg, IL, USA) on samples previously metallized with gold in a sputter Quorum,
model Q150T-S.
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